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Neurotoxicity of 3, 4-Methylenedioxymethamphetamine (MDMA, ecstasy) is still controversially discussed. 
MDMA is an amphetamine derivative that has gained significant popularity in recent years and has 
become the recreational drug of choice for many young, adolescents and adults. This study sought to 
investigate that MDMA causes a behavioral, biochemical and neurocytoarchitechural change in male 
adolescent mice. Fifteen adolescent male mice were used for this study. They were randomly divided 
into 3 groups, of five mice each, control group received normal saline (Ctrl), 5 mice received 10 mg/kg 
of MDMA, s.c (LoD) and another 5 mice received 20 mg/kg of MDMA, s.c (HiD). The animals were 
subjected to behavioural tests to check their motor activity. Biochemical analysis to test for the level of 
catalase and monoamine oxidase activity was also done. The motor activity of animals treated with 10 
mg/kg and 20 mg/kg of MDMA was significantly (p < 0.05) lower when compared with the control. 
Likewise, there was a reduction in the catalase and monoamine oxidase activity in the treated groups. 
In the cerebellum, cellular distortion was seen in the treated group.  It could be concluded that MDMA 
affects the motor activity of the treated animals and thus cause an alteration in the 
neurocytoarchitechure, catalase and monoamine oxidase activities of the animals. 
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INTRODUCTION 
Neurotoxicity of 3, 4-
Methylenedioxymethamphetamine (MDMA, 
ecstasy) is still controversially discussed. MDMA 
is an amphetamine derivative that has gained 
significant popularity in recent years and has 
become the recreational drug of choice for many 
young, adolescents and adults (Bankson and 
Cunningham, 2001). Like amphetamine, MDMA 
elicits hyperactivity when administered to 
rodents. Unlike amphetamine, which has effects 
mediated by the release of dopamine (DA) from 
nerve terminals, MDMA-induced hyperactivity is 
thought to be dependent upon the release of 5-
hydroxtryptamine (5-HT, serotonin) (Bankson 
and Cunningham, 2001). The positively rated 
effects of MDMA consumption include euphoria, 
arousal, enhanced mood, and increased 
sociability, a general sense of well-being, 
decreased anxiety and heightened perceptions 
as a hallmark of the MDMA experience (Morgan, 
2000; Parott, 2001). Some common adverse 
reactions are nausea, headache, tachycardia, 
bruxism, and trismus (Meyer, 2013). Lowering of 
mood is an aftereffect that is sometimes 
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reported from 2 to 5 days after a session of 
ecstasy use (Meyer, 2013). 
The United Nations estimated that global ecstasy 
use affects some nine million people of the 
population between 15 and 64 years. There are 
more than three million ecstasy users in Europe 
accounting for 36% of ecstasy users worldwide. 
The annual prevalence rate of ‘ecstasy’ use is 
estimated at 0.9% of the population age 15-64 
in the west and central Europe, exceeding the 
level reported from North America (0.8%) 
(UNODC, 2007). 
In the European Union (EU), the European 
monitoring center on drugs and drugs addiction 
estimated that more than one million adults take 
ecstasy every month. In the United Kingdom 
(UK) alone, it is estimated that every weekend, 
500,000 young people consume the drug 
(EMCDDA, 2007). Traditionally, population 
surveys have shown that after cannabis, 
amphetamines are the most commonly used 
illegal substances (Johnston et al., 2008). The 
aim of this work is to access the behavioral, 
biochemical and neurocytoarchitechural changes 
in the hippocampus and cerebellum of 
adolescent mice after the induction of MDMA. 
 
MATERIALS AND METHODS 
Experimental animals 
Fifteen (15) adolescent male mice were used for 
this study. The animals were obtained from the 
animal holding facility of Afe Babalola University, 
Ado-Ekiti, Nigeria. The animals were allowed to 
acclimatize for 5 days and had free access to 
standard pellet (purchased from the ABUAD feed 
mill, Ado-Ekiti) and clean water. 
Experimental design 
The mice were randomly divided into 3 groups, 
of 5 mice each in a standard laboratory 
environment with controls humidity, pressure, 
and temperature. The treatment protocol was in 
accordance with the ethical requirement of the 
Animal Use and Care Committee of Afe Babalola 
University, Ado-Ekiti, Nigeria. Control group 
received normal saline (Ctrl), low dose received 
10 mg/kg, s.c MDMA (LoD) and high dose 
received 20 mg/kg, s.c MDMA (HiD). The mice 
were treated for 21 days. 
Drug 
The drug was requested by P.A. Adeniyi from the 
National Drug Law Enforcement Agency (NDLEA) 
head office for the research. The drug was 
delivered to him with a letter with ref no. 
NDLEA/DP/3/VOL.1. The total of 14.64 mg of 
MDMA was used for the study. 
Behavioral analysis 
The behavioral tests were carried out in a closed 
area with proper illumination and sound control 
behavioral room of Afe Babalola University 
holding. 
All behavioral test performance was captured 
using a digital video recorder and were later 
analyzed. The following tests were carried out; 
• Rotarod test: rotarod test were done to 
assay for motor coordination (Deacon, 
2013). The animals were placed on a 
rotarod as described by Perrine and 
Takesue (1968) to determine the latency 
of fall (LOF) and passive rotation (PR). 
The maximum duration allowed was 5 
minutes. 
• Open field test (OFT): This was done 
to test for the locomotive activities of the 
mice. OFT was made of white wood with 
dimensions, 100cm wide, 100cm long, 
and 50cm high and was marked with 
dark lines dividing the floor into 16 
uniform square and a center square. A 
high definition video recording system 
(SONY) was placed in a position to 
capture all corners and sides of the open 
field area (OFA) in order to record animal 
movement and behavior (Ajonijebu et al., 
2014). For the actual test, the animals 
were allowed to freely move about for 5 
minutes following which analysis was 
done for the total locomotive activity of 





the mice using the following equation 
(Adeniyi and Olatunji, 2015). 
Total locomotive activity (TLA) = sum of 
line crossed + number of rearing  
Animal sacrifice 
After administration, two (2) mice from each 
group were sacrificed by cervical dislocation on 
day 21 of the treatment and their brains were 
perfused with 10% formalsaline and transferred 
quickly to a specimen bottle containing 10% 
formalsaline (Baron, 1986; Adeniyi, 2010). 
Thereafter, the hippocampus at bregma -
1.82mm using stereotaxic atlas (Franklin and 
Paxinos, 2007) and cerebellum was excised to 
process for histological analysis. Also, the other 
three (3) mice from each group were sacrificed 
by cervical dislocation and their brain were 
harvested and transferred into 30% sucrose in a 
frozen environment in order to preserve the 
chemicals for biochemical analysis. 
Histological analysis 
After the tissue samples were fixed 10% 
formalsaline, they were dehydrated, embedded 
in paraffin wax and sectioned with a rotary 
microtome at 5 µm. They were then stained in 
cresyl echt violet stain and PTAH 
(phosphotungstic acid hematoxylin) stain to 
demonstrate for the glial fibers, nissil substance 
in neurons and of astrocyte respectively. 
Routine H&E (hematoxylin and eosin) stain were 
also been used to give a general overview of the 
tissues.   
 
Biochemical analysis 
The biochemical assay was done to ascertain the 
catalase activity in the tissue samples as well as 
the monoamine oxidase (MAO) activity. 
 
Statistical analysis 
The data used were generated from the 
recorded videos manually. A number of the 
perpendicular lines crossed was used to 
determine the locomotive activity. The data was 
plotted in one-way ANOVA (GraphPad Prism 
Version 6.0) with Tukey posthoc test. 
Significance was set at ∗ 𝑃 < 0.05 and results 
were expressed as means ± standard error of 




Gross morphological observations 
There were no changes in the skin color and the 
color of their eyes was normal compared to the 
control groups throughout the administration 
period. During the course of administration, it 
was observed that HiD animals were relatively 
more alert to their environment and showed 
restless when compared with the control and 
LoD animals. Similarly, comparing the LoD 
animals showed more agility and sensitivity than 
the control. After the 1st week of administration, 
an increase in body weight was observed in all 
groups throughout the experiment but no 
significant difference (p > 0.05) in weight 
change was observed throughout (see fig. 1). 
 
Motor Activity 
Rotarod test: a significant decrease in LOF was 
observed in LoD animals (𝑃<0.05) when 
compared with the control. Also, decrease in LOF 
was observed in HiD animals when compared 
with control. HiD animals showed greater LOF 
when compared with LoD animals but no 
significant difference (p>0.05) was observed. 
Open field test (OFT): LoD animals show 
significantly low locomotor activity compared to 
HiD animals and control group (p<0.05). No 
significant difference was observed between the 
control group and HiD animals (P>0.05). 
 







LoD animals show significant reduction of 
catalase activity compared to the control 
(p<0.01). No significant difference was observed 
between control and HiD animals. High dose 
treated animals had high catalase activity than 
the low dose treated group but no significant 
difference between the two groups. 
Monoamine oxidase (MAO) activity: 
Monoamine oxidase activity of LoD animals is 
significantly lower than the control group 
(P<0.01). HiD animals show low MAO activity 
than the control group and higher activity than 
LoD animals but no significant difference was 
observed (P>0.05).  
Histological observations 
Hippocampus: 
The LoD possess more granular cells than the 
control group in terms of density, although 
relatively they are similar. HiD is not densely 
packed due to its invasion into the molecular 
layer. The granular cells are not in clustering 
orientation. The cells in HiD are quite scattered 
and display lesser denseness in orientation when 
compared with LoD which is relatively more 
packed. In LoD and the control group, their 
fibers were not so picked by the stain, but the 
LoD seems to appear more densely packed with 
more glial cells in a dense orientation than the 
control group. Comparing the control group and 
the HiD, the difference in both groups is quite 
significant with HiD appearing more densely 
packed than the control group. In comparing the 
treated groups, the LoD appearing similar to the 
control group making it relatively less dense than 
the HiD in terms of glial fibers and glial cells. 
 
Cerebellum: 
Comparing the control group and low dose 
treated group (LoD), the cells in LoD appears 
more densely packed than the control group and 
are also the cells are more deeply stained. Also 
in the high dose treated group (HiD), the cells 
appeared freely packed, but their 
cytoarchitecture appears similar to the control 
group. The Purkinje cells in LoD and HiD are 
majorly distorted with LoD cells shape appeared 
like it going through necrosis. Unlike the treated 
groups, the control group is normally shaped 
(oval) with slight vacuolation. LoD group appears 
to have lesser stained neuronal cells when 
compared with the control group. In terms of 
density and sparseness of neuronal cell, the 
control group appeared to be denser than HiD. 
Overall, both LoD and HiD show similarities in 
terms of cellular density and arrangement in the 
tissue. Comparing the control and the treated 
groups, the shape of the Purkinje cells in the 
control group are oval with no sign of distortion 
but in the LoD and HiD major distortion of the 
cell shape from an oval shape to spherical shape 
was been observed as well as vacuolation. 
Comparing the HiD and LoD, HiD appeared to be 
more prominently distorted. LoD treated group 
appeared to possess more cells than the control 
group but the glial fibers are not easily identified 
but in the control group, the fibers are clearly 
visible. Like the LoD, HiD to have almost no signs 
of glial fibers but still dominate in the density of 
glial cells when compared with the control group. 
LoD possesses more glial cells than HiD in terms 
of density. Observing at X100, the control group 
has more visible glial cells and fibers when 
compared with the treated groups due to lesser 
density in the glial cells and fibers. Comparing 
HiD and LoD, HiD appears to have more densely 
packed glial cells and fibers making it not quite 
visible. 
 






Figure 1: Line graph showing average body weight change of the experimental animals for 3 weeks. There is no significant 




Figure 2: Graph showing the motor activity of the experimental animals. Latency of fall (LOF) of animals treated with 10mg/kg 
of MDMA is significantly lower than the control group (*p < 0.05) (left image). The locomotor activity of the experimental 
animals are shown in the right image. Animals with 10mg/kg of MDMA is significantly lower than the high dose treated animals 
and the control group (*p < 0.05). 
 







HiD: high dose (20mg/kg) 
of MDMA

































Figure 3: Graph showing the biochemical assays (catalase (L) and monoamine oxidase (R) activity) of experimental animals. 
Animals treated with 10mg/kg of MDMA is significantly lower than the control group (**p < 0.01). Monoamine oxidase (MAO) 




Figure 4: Histological slides showing the CA1, 2 and 3 and Dentate gyrus (DG) region of the hippocampus (X10, H&E). GL 
(granular layer), ML (molecular layer) 







Figure 5: Histological slides showing the CA1, 2 and 3 and Dentate gyrus (DG) region of the hippocampus (X10, PTAH). GL 
(granular layer), ML (molecular layer) 
 
Figure 6: Histological slides showing the granular layer, Purkinje cell layer and molecular layer of the cerebellum (X100, H&E 
and PTAH). 






Gross morphology and general 
observations 
In the present study, no morphological changes 
were observed (skin and eyes color) in the 
treated animals when compared with the 
control. Addict or drug dependent people usually 
don’t exhibit changes in the skin color as well as 
eyes color in the short term. Although there were 
changes in the average body weight, but there 
is no significance difference between the treated 
groups when compared with control group at 
95% confidence interval (p > 0.05) (see figure 
1). During the period of administration, some 
behavioural changes were observed in the 
animals treated with different doses of MDMA 
(10 mg/kg and 20 mg/kg s.c) when compared 
with those in the control group; the treated 
animals were relatively more alert to their 
environment (an indication of an increase in 
anxiety level) and showed restlessness when 
compared with the control group. 
Monoamine oxidase (MAO) activity 
MAO is a family 
of enzymes that catalyze the oxidation of mono
amines (Tiptpn et al., 2004; Edmondson et al., 
2004). They are found bound to the outer 
membrane of mitochondria in most cell types in 
the body. MAO helps in catalyzing the 
breakdown of dopamine to dihydroxy 
phenylacetic acid (DHPA) which is a direct 
precursor of dopamine. Biochemical analysis of 
the experiment animals in this study showed a 
significance reduction in the monoamine oxidase 
(MAO) activities (see figure 5) when compared 
with the control (P<0.01); this result agreed with 
findings of Efihirnia et al, (1994) MDMA had been 
reported to act has MAO activity inhibitor by 
preventing the conversion of dopamine in the 
synaptic cleft into DHPA (Efthimia et al., 1994). 
A significant reduction in MAO activity will result 
in a reduction in DHPA leading to high level of 
dopamine in the system. The 
accumulation/retention of dopamine in the 
system will result in hyperexcitation and if this 
continues for a longer period would result in 
excitotoxicity, glial cell activation (indicated by 
the prominent glial fibers), gliosis and neuronal 
death (See figure 15). 
Catalase activity 
Free radicals are atoms or groups of atoms with 
an odd (unpaired) number of electrons and can 
be formed when oxygen interacts with certain 
molecules (Orchin et al., 2005). Once formed 
these highly reactive radicals can start a chain of 
reaction. These free radicals are very reactive 
and they can react with most of the micro-
molecules in the system even with those that 
normally doesn’t react in their natural state such 
as DNA. Their chief danger comes from the 
damage they can do when they react with 
important cellular components such as DNA, or 
the cell membrane; this in cells dysfunction and 
eventually can result in cell death (Conte et al., 
1996). To prevent free radical damage the body 
has a defense system of antioxidants, free 
radicals scavengers, e.g. catalase. Catalases are 
antioxidants that catalyze the conversion of 
hydrogen peroxide to water and oxygen, using 
either an iron or manganese cofactor (Zámocký 
and Koller, 1999; Chelikani et al., 2004). This 
protein is localized to peroxisomes in 
most eukaryotic cells (del Rȋo et al., 
1992). Catalase is an unusual enzyme since, 
although hydrogen peroxide is its only substrate, 
it follows a ping-pong mechanism. Here, its 
cofactor is oxidized by one molecule of hydrogen 
peroxide and then regenerated by transferring 
the bound oxygen to the second molecule of the 
substrate (Hiner et al., 2002). The result from 
this study reveal that MDMA significantly 
decreases (P<0.01) the level of catalase activity 
in the brain of the MDMA-treated groups when 
compared with the control (see figure 4). As a 
result of the reduction in the level of catalase 
activity in the brain of the treated animals this 
could lead to an increase in oxidative stress as 
reported by Brioukhanov et al. (2006). Increase 
in the free radicals in the brain has been reported 
to result in the decrease in density of 





dopaminergic receptors in the brain (Tiago et al., 
2004) and this will result in having more 
dopamine in the system for longer period of time 
which in turn results in hyper-excitation, cell 
death, glial activation, and gliosis (Bjӧrklund and 
Dunnett, 2007). 
Neurobehaviour 
MDMA is a psychoactive drug that acts on the 
different neurotransmitters (dopamine and 
serotonin) to have it effect. It is shown that 
MDMA induces serotonin syndrome in rodent 
(Isbister et al., 2007). Most users of MDMA 
abuse it with other drugs. A symptom of 
serotonin syndrome in the rodent is a jerky 
movement of the limbs this has been attributed 
to excess serotonin and dopamine at the 
synapse (Ener et al., 2003). This study shows 
that animals treated with MDMA had lower motor 
function compared with the control (Fig. 2 and 
3). Other studies have reported the similar 
observation that MDMA affect motor 
coordination and memory function (Callaghan et 
al., 2006; Li et al., 2006; Capela et al., 2009). 
Altered motor coordination may be due to the 
effect of the serotonin syndrome as the animal 
may not be able to balance well on the rotarod 
bar, although animal given the higher dose (20 
mg/kg, s.c) still perform more than the lower 
dose (10 mg/kg, s.c). The explanation for this 
looks tricky but epigenetic modification of the 
receptors at a higher dose may be a cause. It 
has been reported that alcohol which is another 
psychoactive agent has a different effect on 
dopamine release at acute and chronic state 
(Boileau et al., 2003). In this study, it was 
observed that the total locomotive activity of 
animals treated with 10 mg/kg of MDMA was 
significantly (P<0.05) lower than the control 
group. No significant difference was observed 
between the control group and the high dose 
treated animals (p >0.05). 
Neurohistology 
The cerebellum plays an important role in motor 
function. Muscular input through mossy fibers 
project to the cerebellum, synapsing of the 
granular cells which later project to the Purkinje 
cells (Loewenstein et al., 2005). Purkinje 
neurons are the inhibitory neurons in the 
cerebellum which helps in modulating the 
cerebellum firing. This finding shows that 
animals given 10mg/kg (s.c) of MDMA have 
more compacted granular cell layer than the 
control and the high dose (20mg/kg, s.c) (see 
fig. 13). Most input into the cerebellum enters 
into the granular cell layer to make a synapse 
before later relating to the Purkinje cells for 
modulation. Observations of the Purkinje cells 
indicate that animals given 10 mg/kg BW of 
MDMA have distorted Purkinje cells than the 
control, the effect of high dose been higher as 
there are lesser Purkinje cells. Since Purkinje cell 
is the only inhibitory neuron in the cerebellum, 
fewer Purkinje cells will lead to lesser inhibition 
of cerebellar output (Yartsey et al., 2009). This 
correlate with the behavioral result as animals 
given MDMA has low motor coordination (fig. 2 
and 3). Lesser Purkinje cells lead to disinhibition 
of the cerebellar output thereby increasing the 
crude motor movement (Loewenstein et al., 
2005), this makes fine movement coordination 
impossible.  
The Glial cells and fibers are more stained in the 
treated group with higher dose showing more 
stain (see fig.14). Increase in glial cells especial 
the microglia is a sign of inflammation (Dissing-
Olesen et al., 2007). Since MDMA inhibit MAO 
activity leading to excess dopamine at the 
synapse (Efthimia et al., 1994). Astrocyte has 
been shown to have receptors for 
neurotransmitters and help in mopping up 
excess neurotransmitters from the synapse 
(Figley and Stroman, 2011) and thereby by the 
result in their activation if prolonged. This 
explains why more microglia are been generated 
to clear off dead neuron, in the same way, more 
the astrocyte is been generated take up the 
excess neurotransmitters at the synapse. This 
may be a reason for increase in the No. of 
cells/unit area in the treated animals when 
compared with the control (see fig.9) 
Research has shown that the hippocampus and 
the cerebellum are connected polysynaptically 





(Yu et al., 1989). This connection has been 
attributed to the function of the place cells in the 
hippocampus, the place cells are responsible for 
familiarizing with previous locations and areas. 
Studies show that the place cell depends on cues 
from the cerebellum (Rochefort et al., 2011) and 
report of experience of patients with cerebellar 
lesion shows that they have cognitive deficit 
especial matching space with time 
(Schmahmann, 1998). The present work shows 
that more granular cells were seen in the treated 
group (see fig. 11), the hippocampal-cerebellar 
connection involves the projection from CA1 and 
CA3 to lobule VI of the cerebellar cortex (Yu et 
al., 1989). Although, the cerebellum have been 
hypothesized to involve in higher cognitive 
function (Timmann and Daum, 2007). This study 
shows that MDMA increases the cell count in all 
areas of the hippocampus (CA1, CA2, 3 and DG) 
(fig. 6 – 8). Adeniyi et al. (2015) show that low 
dose (2 mg/kg, s.c) of MDMA reduced cell count 
in all areas of the hippocampus after a short 
period of time. This is not consistent with the 
present result which shows that 10 mg/kg and 
20 mg/kg of MDMA increase the cell count in all 
regions of the hippocampus for 21 days. 
Although memory test was not done in this 
study, Adeniyi et al. (2015), shows that MDMA 
did not affect spatial memory at the dose used. 
We hypothesized that MDMA at 10 mg/kg and 
20mg/kg in mice may affect spatial memory 
since hippocampus spatial memory processing 
depends on cues from the cerebellum as 
reported (Tomlinson et al., 2014). 
In conclusion, Administration of MDMA (in short 
term) have no significant effect on the gross 
morphology of the animal. MDMA causes the 
excess release of neurotransmitters at the 
synapse as well as alteration in some 
biochemical metabolite involve in the 
metabolism of these neurotransmitters. The 
motor activities of animals treated with MDMA 
are affected. MDMA affect the cytoarchitecture 
of the brain cerebellum and the hippocampus 
bringing above cell death in the cerebellum as 
well as the proliferation of more glial cells in the 
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